4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-028538
Chief Scientific Officer sold 3,000 shares at $81.81 ($245,430)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-05-07 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-05-07 | Sale | −3,000 | $81.81 | $245,430 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-05-07 | Option exercise · Stock options (right to buy) | +3,000 | 22,154 | D | ||
| Open-market sales · 3,000 sh · avg $81.81 · $245,430 | |||||||
Loading xslF345X03/doc4.xml…